To define the effects of rationally designed antimicrobial peptides (AMPs) on macrophage polarization and function, particularly in the context of LPS-induced inflammation.
Approach:
Key Findings:
Designed AMPs suppress pro-inflammatory cytokine production while enhancing anti-inflammatory responses.
The potency of synthetic AMPs is comparable to that of the natural AMP LL-37.
AMPs mitigate the impact of LPS-induced inflammation and influence key molecular pathways such as IRF3/IRF4 and PPAR-γ, favoring M2 polarization.
The amphiphilic, sequence-engineered design of the peptides allows for controlled membrane interaction and low cytotoxicity.
Interpretation:
Limitations:
The study primarily utilizes an in vitro model, which may not fully replicate in vivo conditions.